Year: 2017
Type: article
Abstract: The promise of targeted therapeutics for a defined oncogenic molecular lesion is always tempered by the likelihood of acquired resistance to the pharmacological or biologic agent. A prominent mode ...
Source: Cell Cycle
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2595072670